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Background. A large amount of mushroom waste is generated during mushroom production 34 
(account for up to 20% of total production) and is mainly composed of mushrooms that do not 35 
meet the specifications set by retailers because of misshapen caps and/or stalks. Mushrooms are 36 
notable for their ergosterol (a precursor of vitamin D2) content which is converted to vitamin D2 37 
after exposure to natural or artificial ultraviolet (UV) irradiation. Therefore, mushroom waste 38 
could be used as a source for the recovery of both ergosterol and vitamin D2 which could be 39 
valorized by both pharmaceutical and food industries.  40 
Scope and approach. The current review presents a comprehensive summary of research 41 
performed regarding the extraction, purification and determination of ergosterol and vitamin D2 42 
(ergocalciferol) from mushroom matrices. Additionally, studies related to the impact of sample 43 
preparation and especially of drying methods on the retention of ergosterol and vitamin D2 are 44 
presented. Finally, the potential valorization of mushroom waste sterols by food and 45 
pharmaceutical industries is discussed.  46 
Key Findings and Conclusions. Ergosterol and vitamin D2 contents vary among different 47 
mushroom species. Sample drying is a crucial step that precedes sterol extraction and has a 48 
significant impact on the retention of ergosterol and vitamin D2. The extraction of sterols from 49 
mushroom can be conducted by either conventional (e.g., Soxhlet extraction) or non-conventional 50 
methods (e.g., ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE), deep 51 
eutectic solvents (DES) extraction, supercritical fluid extraction (SFE), and pressurized liquid 52 
extraction (PLE)) or their combination. The application of non-conventional methods such as UAE 53 
and MAE facilitate in shorter extraction times than the conventional methods. The valorization of 54 
mushroom extracts enriched in ergosterol and vitamin D2 by both pharmaceutical and food 55 
industries requires further work. 56 
 57 








1. Introduction 64 
Mushrooms are a unique source of compounds such as polyphenols, amino acids (i.e. 65 
ergothioneine), polysaccharides (i.e. β-glucans), terpenoids, vitamins (i.e. vitamin D2), and sterols 66 
(i.e. ergosterol) which have been linked to antioxidant, anticancer, antidiabetic, anti-inflammatory, 67 
hepatoprotective, antiallergic, antimicrobial, and antiviral activities (Kalač, 2016; Roncero-Ramos 68 
& Delgado-Andrade, 2017; Kalaras et al., 2017; Ramos et al., 2019). Because of their beneficial 69 
properties, mushrooms have become attractive as functional foods or as a source of compounds 70 
that can be extracted and incorporated into food products.  71 
Vitamin D is an essential vitamin for human health and plays a vital role in the regulation 72 
and maintenance of calcium homeostasis. Vitamin D deficiencies have also been linked to an 73 
increased risk of cancer, hypertension, autoimmune diseases, and diabetes (Jäpelt & Jakobsen, 74 
2013). The main reasons for failing to meet vitamin D requirements are i) low dietary intake, since 75 
only a few food products naturally contain vitamin D and ii) limited vitamin D synthesis due to 76 
inadequate exposure to sunlight (Bailey et al., 2010; Jäpelt & Jakobsen, 2013).  77 
Vitamin D is a fat-soluble vitamin (non-polar compound) which is found in two major 78 
forms, namely D2 and D3 (Dawson-Hughes et al., 2010). The D3 form is mainly contained in animal 79 
products such as egg, meat, and fish, while the D2 form is mostly present in mushroom fruiting 80 
bodies. Mushrooms contain high levels of ergosterol, a precursor of vitamin D2. The 81 
transformation of ergosterol to vitamin D2 can be achieved by the application of artificial or natural 82 
ultraviolet (UV) irradiation (Wen et al., 2020).  83 
Ergosterol, the precursor of vitamin D2 is the most abundant sterol found in fungal cell 84 
membranes where it is critical for maintaining fluidity, permeability, carrying out various kinds of 85 
endocytosis and trafficking and for the cytoskeletal organization (Abe & Hiraki, 2009). In yeast 86 
mating, it is also linked with pheromone signalling and membrane fusion (Jin, McCaffery, & 87 
Grote, 2008). Recently, it has been suggested that ergosterol also has an immunoactivity role, as 88 
it is involved in triggering programmed cell death in host cells (Rodrigues, 2018). 89 
High amounts of mushroom waste are generated during mushroom production (account for 90 
up to 20% of total production). Mushroom waste is mainly composed of mushrooms that their caps 91 
and/or stalks are misshapen and do not meet the specifications set by retailers (Aguiló-Aguayo, 92 
Walton, Viñas, & Tiwari, 2017). These mushroom by-products have high nutritional value. 93 
Moreover, their disposal is linked to managing costs and high environmental impact including 94 
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global warming, abiotic depletion, acidification, ozone layer depletion, eutrophication, human 95 
toxicity, eco-toxicity, depletion of natural resources, and energy consumption (Leiva, Saenz-Díez, 96 
Martínez, Jiménez, & Blanco, 2015). Therefore, new alternative and profitable solutions need to 97 
be explored (Royse, 2014). Mushroom waste could be utilized for the preparation of extracts 98 
enriched in vitamin D that could be used either by the pharmaceutical industry as nutritional 99 
supplements or by the food industry as an additional ingredient in foods, adding value to the 100 
agriculture sector.  101 
The recovery of ergosterol and vitamin D is carried out by the application of either 102 
conventional methods such as Soxhlet extraction or non-conventional such as ultrasound-assisted 103 
extraction (UAE), microwave assisted extraction (MAE), deep eutectic solvents (DES), 104 
supercritical fluid extraction (SFE), and pressurized liquid extraction (PLE) (Heleno, Diz, et al., 105 
2016; Heleno, Prieto, et al., 2016; Morales et al., 2017; Patil, Ghodke, Jain, & Dandekar, 2018). 106 
Extraction method might have a significant impact on the recovery of both ergosterol and vitamin 107 
D2, therefore, the extraction conditions should be carefully selected and optimized. The application 108 
of some non-conventional methods such as UAE and MAE may facilitate the avoidance of 109 
saponification step reducing the total extraction time. Apart from the extraction, sample 110 
preparation may impact the retention of vitamin D and ergosterol in samples (Gąsecka et al., 2019; 111 
Tian, Zhao, Huang, Zeng, & Zheng, 2016). 112 
The current review summarizes the steps from sample preparation until the detection of 113 
ergosterol and vitamin D from mushrooms, as well as their potential application in the food and 114 
pharmaceutical industries.  115 
 116 
2. Ergosterol and vitamin D2 in mushrooms 117 
Vitamin D occurs in two main forms in nature: Vitamin D2 (ergocalciferol) and Vitamin 118 
D3 (cholecalciferol). Vitamin D3 is only found in animal sources such as fish liver oils, eggs and 119 
milk products. Vitamin D2 found in limited plant sources in far fewer amounts, putting in 120 
vegetarians and vegans being at risk of having vitamin D deficient diets (Ho-Pham, Vu, Lai, 121 
Nguyen, & Nguyen, 2012). Mushroom qualify for such a diet and while they are deficient in 122 
vitamin D, widely available ones such as shiitake and button mushrooms, are rich sources of 123 
ergosterol, a precursor of vitamin D2. Ergosterol can be converted into vitamin D2 by natural or 124 
artificial UV irradiation which is a process that has been widely studied (Black, Lucas, Sherriff, 125 
Bjorn, & Bornman, 2017; Taofiq, Fernandes, Barros, Barreiro, & Ferreira, 2017).  126 
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Mushrooms and other kinds of fungi have high concentrations of ergosterol in their cell 127 
membranes where it performs a role similar to that of cholesterol in animals and sitosterol in plants, 128 
i.e., strengthening and maintaining fluidity of cell membranes, protein functionality, and 129 
modulating intracellular transport (Lingwood & Simons, 2010; Roncero-Ramos & Delgado-130 
Andrade, 2017). It is produced by a fungal specific pathway. Similar to animals, fungi convert 131 
acetyl-CoA to lanosterol via the formation of squalene epoxide, however, fungi have a longer and 132 
more energy-expensive conversion final process in which 11 oxygen atoms are added to lanosterol 133 
to produce ergosterol whereas animals add 10 oxygen atoms in a more efficient process to produce 134 
cholesterol (Dupont et al., 2012).  135 
Figure 1 shows the process of conversion of ergosterol in fungal sources into vitamin D2. 136 
On exposure to UV radiation, ergosterol in exposed portions of mushrooms undergoes 137 
photochemical cleavage in the B ring, leading to the formation of an intermediate called pre-138 
vitamin D2. On subjection to heat, this intermediate undergoes thermal isomerization to form 139 
ergocalciferol, i.e., vitamin D2. The yield of the final product is heavily dependent on the balance 140 
between thermal and photochemical reactions (Jasinghe, Perera, & Sablani, 2007), hence the 141 
temperature of radiation is critical. Higher temperatures direct the reaction towards the formation 142 
of by-products such as lumisterol and tachysterol, in addition to adversely affecting the texture and 143 
colour of the mushrooms. Moisture content is also important since excessive dryness leads to an 144 
increase in surface area and hence exposure to oxygen, which leads to oxidation of vitamin D2. On 145 
the other hand, excess moisture may have a dilution effect on ergosterol content, which might 146 
result in a lower conversion rate to vitamin D2 (Jasinghe et al., 2007). However, the total amount 147 
of ergosterol produced per gram of mushroom might not be affected by the excess moisture 148 
content. Hence, the vitamin D2 fortification process in mushrooms should go hand in hand with 149 
minimizing moisture loss and maintaining hardness. The optimal conditions vary with types of 150 
mushrooms and there have been many studies to determine them (Ahn, 2018; Lee & Aan, 2016; 151 
Won et al., 2018). 152 
 153 
3. Extraction and determination of ergosterol and vitamin D2 from mushrooms 154 
Ergosterol and vitamin D2 extraction requires long determination times. Several steps are 155 
involved in the extraction and determination of ergosterol and vitamin D2 from mushrooms 156 
including sample preparation, saponification, extraction, cleaning, as well as detection and 157 
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quantification using HPLC or GC. The first step for the extraction of ergosterol and vitamin D2 is 158 
sample preparation. Although samples can be either fresh or dried, most of the studies have 159 
determined sterols in lyophilized samples (Heleno et al., 2016a; Heleno et al., 2016b; Teichmann, 160 
Dutta, Staffas, & Jägerstad, 2007; Wittig, Krings, & Berger, 2013). To date, not much work has 161 
been done on the bulk recovery of ergosterol and vitamin D2 from mushrooms but that there is 162 
much to be learned from work done on its analytical determination.  163 
 164 
3.1 Sample preparation 165 
Sample preparation precedes extraction and determination steps. Studies have shown that 166 
sample preparation may have a significant impact on the sterol content of different mushroom 167 
species (Gąsecka et al., 2019; Nölle, Argyropoulos, Müller, & Biesalski, 2018). Recently, Gąsecka 168 
et al. (2019) reported that the ergosterol content of two mushroom species (Hericium erinaceus 169 
and Leccinum scabrum) was significantly affected by the processing method employed. 170 
Specifically, the authors noted that the ergosterol content was higher in the fresh mushroom 171 
samples while it declined as the drying temperature increased from 20 to 70 °C (Gąsecka et al., 172 
2019). Slawinska et al. (2016) investigated the effect of hot-air drying (the initial drying 173 
temperature was 40 °C, and in the final stage of drying the temperature was raised to 60 °C) and 174 
freeze-drying on ergosterol and vitamin D2 contents of three different mushroom species (Agaricus 175 
bisporus, Pleurotus ostreatus and Lentinula edodes). The authors reported that the vitamin D2 176 
content was higher in the mushrooms dried by freeze-drying than those dried by hot-air drying, 177 
while drying treatment had a slight significant effect only on the ergosterol content of A. bisporus 178 
(Slawinska et al., 2016). Similar results were reported by Bernas and Jaworska (2017) where 179 
ergosterol content was higher in freeze-dried A. bisporus than its air-dried counterpart (30% loss). 180 
Tian et al. (2016) examined the effect of different drying methods (microwave vacuum-drying 181 
(microwave power density of 15 W/g, vacuum degree of −80 kPa, for 11 min), hot-air drying (60-182 
70 °C), microwave-drying (539 W for 18 min), vacuum-drying (−90 kPa at 60 °C for 15 h)) on 183 
shiitake mushroom nutrient retention, including vitamin D2. The authors noted that drying resulted 184 
in the degradation of vitamin D2, with the hot-air and microwave-drying resulting in greater 185 
vitamin D2 loss, compared to the other two drying techniques (Tian et al., 2016). These results 186 
show the sensitivity of vitamin D2 to degradation in the presence of oxygen. Nölle et al. (2018) 187 
investigated the effect of a high precision drying (temperatures: 40, 60, and 80 °C, specific 188 
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humidity: 10 g/kg, and air velocity: 0.6 m/s) and freezing-drying on the retention of vitamin D2 of 189 
different mushroom species, including shiitake (L. edodes), oyster (P. ostreatus), as well as white 190 
and brown button mushrooms (A. bisporus) treated with UV-B light (1.5 J/cm2). In the case of 191 
oyster and white button mushrooms, the highest vitamin D2 content was found in the freeze-dried 192 
samples, while for shiitake and brown mushrooms there was insignificant difference between the 193 
freeze-dried and hot-air dried samples. Therefore, it can be concluded that the drying process 194 
should be carefully selected according to the mushroom species.  195 
 196 
3.2 Extraction of ergosterol and vitamin D2 197 
Conventional (e.g., Soxhlet extraction) and non-conventional (e.g., microwave-assisted 198 
extraction (MAE), ultrasound-assisted extraction (UAE), deep eutectic solvents (DES), 199 
supercritical fluid extraction (SFE)) methods have been investigated and developed for the 200 
recovery of ergosterol and vitamin D2 from mushrooms (Heleno et al., 2016a; Heleno et al., 2016b; 201 
Patil et al., 2018) (Figure 2). The current literature portrays different definitions for conventional 202 
extraction. For instance, according to Barba et al. (2017) conventional extraction should be 203 
considered as the extraction protocol using conventional solvents which are toxic to the 204 
environment and human health. According to Heleno et al. (2016b) conventional extraction is a 205 
method that is time-consuming and requires large quantities of hazardous solvents. On the other 206 
hand, as a non-conventional is considered the method that requires a lower temperature and shorter 207 
treatment times compared to conventional methods (Roselló-Soto et al., 2016). Non-conventional 208 
methods have been employed by studies for the recovery of sterols using organic solvents such as 209 
methanol. In this case, even though a non-conventional method is employed the whole process 210 
cannot be considered as environmentally and human friendly since the principles of 'green 211 
extraction' are not satisfied (Chemat, Vian, & Cravotto, 2012). According to Chemat et al. (2012) 212 
'green extraction' is an extraction process that involves: i) reduced energy consumption, ii) the use 213 
of alternative non-toxic solvents and renewable natural products, and iii) results in a safe and high-214 
quality extracts. Table 1 presents the summary of studies conducted to date extracting vitamin D2 215 
and ergosterol from mushroom matrices. The extraction methods are divided considering the 216 
technology used for the extraction rather than the solvent.  217 
 218 
3.2.1 Saponification (hydrolysis)  219 
8 
 
Saponification is a hydrolysis reaction where free hydroxide breaks the ester bonds 220 
between the fatty acids and glycerol of a triglyceride, resulting in free fatty acids and glycerol 221 
(Prabu, Suriya Prakash, & Thirumurugan, 2015). In ergosterol and vitamin D2 extraction from 222 
mushrooms, saponification can be conducted either on samples or on extracts derived from 223 
different extraction methods. When hydrolysis is applied on mushroom samples, it breaks the 224 
complex structure of mushrooms and improves the recovery of ergosterol and vitamin D2 from the 225 
surrounding matrix. Moreover, when conjugated sterols are hydrolyzed to free sterols, they have 226 
similar polarity and can be extracted with a single solvent (Han & Zhou, 2015). The saponification 227 
may take place at temperatures varying from 60 and 80 °C and times varying from 15 to 60 min 228 
(Barreira et al., 2014; Gil-Ramirez et al., 2013; Heleno et al., 2016a). During the hydrolysis, 229 
ascorbic acid solution is used to avoid any thermal degradation of sterols. Recent studies have 230 
shown that saponification step can be avoided when some non-conventional extraction techniques 231 
such as UAE and MAE are employed (Heleno et al., 2016a; Heleno et al., 2016b).  232 
 233 
3.2.2 Non-conventional extraction methods 234 
3.2.2.1 Ultrasound-assisted extraction (UAE) 235 
UAE has been employed for the extraction of different classes of bioactive compounds 236 
from mushrooms such as polyphenols, sugars, and vitamins from different mushrooms species 237 
(Aguiló-Aguayo et al., 2017; Alzorqi, Sudheer, Lu, & Manickam, 2017; Heleno et al., 2016a; Xu 238 
et al., 2016). Ultrasound devices use ultrasound waves above human hearing (>20 kHz) in which 239 
pressure fluctuation leads to the cavitation with the resultant unstable bubbles imploding and 240 
damaging cell membranes allowing for mass transfer out of the cell (Chemat et al., 2017). In sterol 241 
extraction from mushroom, ultrasonic baths have been mainly used with a frequency ranging 242 
between 20 to 65 kHz (Heleno et al., 2016a; Patil et al., 2018; Villares et al., 2012; Villares et al., 243 
2014). Several mechanisms are involved in ultrasound extraction such as fragmentation, erosion, 244 
capillarity, detexturation, and sonoporation and have been described in the depth in the recent 245 
review of Chemat et al. (2017) and summarized in Figure 3.  246 
The extraction of sterols from mushrooms can be influenced by different parameters, such 247 
as solvent type, extraction time and ultrasound power, while liquid-to-solid ratio seems to have no 248 
significant effects (Heleno et al., 2016a). Patil et al. (2018) employed UAE (ultrasonic bath) in 249 
conjunction with deep eutectic solvents (DES) for the extraction of vitamin D2 from A. bisporus. 250 
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The vitamin D synthesis was achieved by exposing the extracts to UV light. Villares et al. (2012) 251 
used UAE (ultrasonic bath) for the recovery of ergosterol from Τuber melanosporum and T. 252 
aestivum using chloroform/methanol mixture (2:1, v/v). After UAE, a clean-up stage of the 253 
extracts was conducted with Oasis MAX column preconditioned with 8 mL of hexane. Sterol 254 
separation from other lipids was conducted by passing chloroform. The solvent in the final extracts 255 
was evaporated under a nitrogen stream and redissolved in 2 mL of chloroform.  256 
Heleno et al. (2016a) optimized the UAE of ergosterol from Agaricus bisporus using 257 
response surface methodology (RSM). In this study the effects of different parameters were 258 
investigated including the type of extraction solvent, liquid-to-solid ratio, extraction time, and 259 
ultrasound power. Among the different solvents investigated, ethanol resulted in the highest 260 
ergosterol yields followed by limonene and n-hexane. Both ergosterol and vitamin D2 are 261 
amphiphilic molecules with small hydroxyl polar heads which allow them to be extracted by a 262 
variety of polar and non-polar solvents (Heleno et al., 2016a; Hsueh et al., 2007). The authors 263 
noted that at the optimal UAE conditions (extraction time of 15 min and ultrasound power of 264 
375W) ergosterol yields were higher than those obtained by a time consuming Soxhlet extraction 265 
method in significantly shorter times (from 4h to 15 min). The authors also claimed that the 266 
saponification step can be avoided when the UAE is employed (Heleno et al., 2016a). However, 267 
the efficiency of the UAE on purifying the extracts is influenced by the solvent used. For instance, 268 
the authors showed that the purity of the extracts obtained by n-hexane and limonene was similar 269 
to the extracts obtained after saponification, while ethanol during UAE resulted in less pure 270 
extracts. This was attributed to the higher polarity of ethanol than the other two solvents which 271 
may lead to the extraction of various compounds (polar and non-polar). In summary, UAE can be 272 
used for the extraction of sterols from mushrooms facilitating shorter extraction times. 273 
 274 
3.2.2.2 Supercritical fluid extraction (SFE) and pressurized liquid extraction (PLE) 275 
SFE and PLE are sustainable extraction techniques that have been used for the recovery of 276 
various bioactive compounds, including polyphenols, pigments, oils, and sterols from different 277 
materials (Aladić et al., 2016; Valadez-Carmona, Ortiz-Moreno, Ceballos-Reyes, Mendiola, & 278 
Ibáñez, 2018). In SFE the use of supercritical CO2 (non-polar) facilitates the recovery of non-polar 279 
and mid-polar compounds (Gallego, Bueno, & Herrero, 2019). SFE has been employed for the 280 
recovery of both ergosterol and vitamin D2 from mushrooms (Gil-Ramirez et al., 2013; Morales et 281 
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al., 2017). Morales et al. (2017) employed SFE for the production of extracts enriched in vitamin 282 
D2. Specifically, SFE was employed for the extraction of ergosterol from shiitake mushrooms and 283 
subsequently, extracts were exposed to UV light for the conversion of ergosterol to vitamin D2. In 284 
this study, two extraction parameters were examined including extraction temperature (°C) and 285 
pressure (bar). Both extraction parameters had a significant effect on the recovery of ergosterol. 286 
The highest ergosterol yields (180 mg/g dw) were obtained at a pressure of 350 bar and a 287 
temperature of 70 °C (Morales et al., 2017). Gil-Ramirez et al. (2013) optimized and compared 288 
the extraction conditions of SFE and PLE for the recovery of sterols from Agaricus bisporus 289 
fruiting bodies. In SFE, extraction pressure and use of co-solvent (10% ethanol) were investigated. 290 
Lower sterol yields were obtained when a co-solvent was used, while there was no significant 291 
effect of the extraction pressure. Fractions containing 60% of sterols were obtained at 40 °C and 292 
30 MPa. In the case of PLE, several parameters were investigated including extraction time, the 293 
number of cycles, ratio mushroom powder/sand and temperature. The optimal PLE conditions 294 
using ethanol as the pressurized solvent were a pressure of 10.7 MPa, a temperature of 50 °C, 5 295 
cycles of 5 min and mushroom/sand ratio of 1:4 (Gil-Ramirez et al., 2013). Between SFE and PLE, 296 
PLE found to extract all the sterols from mushrooms, however, SFE was found to be more 297 
selective. SFE has the potential of being upscaled for the extraction of both ergosterol and vitamin 298 
D2 since it has been upscaled for the extraction of other compounds (e.g., caffeine to make 299 
decaffeinated products) whereas PLE remains a small-scale batch technique with mostly analytical 300 
applications. 301 
 302 
3.2.2.3 Microwave-assisted extraction (MAE) 303 
MAE uses microwaves which are electromagnetic irradiation ranging in frequency from 304 
300 MHz to 300 GHz. MAE has been employed for the extraction of different classes of bioactive 305 
compounds, such as polyphenols, polysaccharides, lipids, and fatty acids (Kumar, Sivacumar, & 306 
Ruckmani, 2016; Maeng, Muhammad Shahbaz, Ameer, Jo, & Kwon, 2017; Sinanoglou et al., 307 
2015). However, only few studies to date have employed and optimized the MAE of ergosterol 308 
from mushrooms while there is no study optimizing the MAE of vitamin D2 from mushrooms 309 
(Young, 1995; Heleno et al., 2016b; Taofiq et al., 2019). Heleno et al. (2016b) investigated and 310 
optimized three parameters named extraction time, extraction temperature and solid-to-liquid ratio 311 
using RSM for the recovery of ergosterol from A. bisporus. The optimal MAE conditions were 312 
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extraction time of 19.4 ± 2.9 min, extraction temperature of 132.8 ± 12.4 °C and the solid-to-liquid 313 
ratio of 1.6 ± 0.5 g/L, yielding 5.56 ± 0.26 mg of ergosterol per g of mushroom by-products. The 314 
authors noted that the extraction yields increased as the extraction time and extraction temperature 315 
increased, while extraction yields decreased as the solid-to-liquid ratio increased. The authors also 316 
reported that the purity of extracts in ergosterol reduced by increasing temperature. This could be 317 
either due to the extraction of other compounds than ergosterol as the extraction temperature 318 
increased, or ergosterol was degraded as the temperature increased (Heleno et al., 2016b). 319 
Recently, Taofiq et al. (2019) optimized the MAE (extraction time (2-25 min) and temperature 320 
(60-150 °C)) of ergosterol (dependent variables examined: extraction yields, purity and total 321 
extraction yields) from A. blazei and compared the dependent variables with those obtained at the 322 
optimal UAE and heat-assisted extraction (HAE). Authors noted that among the different 323 
extraction methods MAE was the most efficient in terms of extraction yields (25.44 ± 5.1 mg/ 324 
100g dw) compared to the UAE and HAE 21.49 ± 0.9 and 18.84 ± 2.3 mg/ 100g dw, respectively. 325 
However, UAE resulted in extracts with higher ergosterol purity which could be attributed to the 326 
combined mechanisms such as fragmentation, erosion and sonoporation that take place through 327 
UAE. MAE is a promising extraction technique that can significantly reduce the extraction time 328 
of ergosterol recovery from mushrooms. Future studies are encouraged to investigate and optimize 329 
the MAE of vitamin D2 (extraction yields and purity) from different mushroom varieties. 330 
 331 
3.2.3  Conventional extraction methods 332 
Currently, the extraction of ergosterol and vitamin D2 from mushrooms is mainly 333 
conducted using conventional extraction methods (Table 1). Soxhlet extraction is used for the 334 
extraction of both sterols, followed by saponification and purification. Heleno et al. (2016a) 335 
employed Soxhlet extraction for the recovery of ergosterol from A. bisporus. Specifically, 4.5 g of 336 
samples were extracted with 150 mL of solvent (the effect of n-hexane, ethanol and limonene was 337 
examined) during 4 h Soxhlet extraction. After the extraction the solvent was rotary evaporated, 338 
and the extracts were saponified using 2 M KOH and 0.1 M ascorbic acid solution at 60 °C for 45 339 
min. Subsequently, the samples were mixed with NaCl solution and n-hexane. Sterols due to their 340 
lipophilic nature were transferred from the aqueous to n-hexane phase. The remained aqueous 341 
layer was reextracted again using n-hexane. Finally, the n-hexane fraction was dried and the 342 
residue was dissolved in methanol (1 mL) before HPLC analysis (Heleno et al., 2016a).  343 
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In most of the studies that have been conducted so far, saponification of mushroom samples 344 
precedes extraction and purification. A protocol that is usually reported in the literature is 345 
saponification of mushroom samples for 30 min to 1 h at 80 or 85 °C, followed by liquid-liquid 346 
extraction using non-polar solvents (i.e., n-pentane). Subsequently, the non-polar phase is washed 347 
with potassium hydroxide 3% (w/v) in 5% (v/v) ethanol and neutralized using deionized water. 348 
Finally, the organic phase fraction is rotary evaporated to dryness and then it is dissolved either in 349 
ethanol or methanol (Heleno et al., 2016a; Jasinghe & Perera, 2005, 2006; Jasinghe et al., 2007; 350 
Ko, Lee, Lee, & Park, 2008). In some studies before saponification an internal standard is added 351 
(Roberts et al., 2008).  352 
 353 
3.3 Determination of ergosterol and vitamin D2  354 
3.3.1 High-performance liquid chromatography (HPLC)  355 
HPLC is the most commonly employed technique for the identification and quantification 356 
of vitamin D2 and ergosterol from mushrooms (Table 2). Before injection, samples are filtered 357 
using disposable filter discs to remove small particles and thus protect HPLC columns. For the 358 
detection of vitamin D2 and ergosterol, reverse phases are usually employed containing carbon 359 
chains of 18 carbon atoms, while there is one study used a column with carbon chains of 30 carbon 360 
atoms (Table 2). The temperature of the stationary phase (column) is a critical parameter that may 361 
affect the retention times of bioactive compounds. In the case of ergosterol and vitamin D2 362 
detection, the temperatures of the stationary phase may vary between 25 and 50 °C. For instance, 363 
in the studies of Yuan, Wang, Liu, Kuang, and Zhao (2007) the stationary phase was maintained 364 
at ambient temperature, while in the study of Morales et al. (2017) the stationary phase was 365 
maintained at 50 °C. For HPLC analysis an injection volume of 10 or 20 μL is usually used, 366 
however, when UHPLC (Ultra-high performance liquid chromatography) is employed, an 367 
injection volume of 1 μL can be used (Slawinska et al., 2016). Either isocratic or gradient elution 368 
can be implemented in HPLC analysis. The combination of methanol and acetonitrile is mainly 369 
used as a mobile phase in isocratic elution while in gradient elution two or three mobile phases 370 
can be used (Ahlborn et al., 2018). The flow rate that is usually employed is 1 mL/min (Ahlborn 371 
et al., 2018; Heleno et al., 2016a; Heleno et al., 2016b; Huang, Lin, & Tsai, 2015; Morales et al., 372 
2017). UV-Vis and photodiode array detectors have been employed for the detection and the 373 
wavelengths that are usually used for the detection of both ergosterol and vitamin D are 264 and 374 
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280 (Table 2). Mass spectrometers (MS) directly or coupled with a PDA detector have also been 375 
used for detecting sterols, including vitamin D2, and ergosterol in mushrooms.  376 
 377 
3.3.2 Gas-chromatography (GC) 378 
In addition to HPLC, the determination of ergosterol and vitamin D2 has been conducted 379 
using GC coupled with MS and/or flame ionization detector (FID) (Gil-Ramirez et al., 2013; 380 
Morales et al., 2017; Teichmann et al., 2007). In the study of Gil-Ramirez et al. (2013), prior to 381 
the injection into the GC system, dried extracts were dissolved in chloromethane: methanol 382 
(ClCH3: MeOH) (2:1 v/v). A capillary column connected to a gas chromatograph equipped with 383 
electronic pressure control, auto injector, a triple-axis mass spectrometer detector, and GC–MS 384 
solution software. Helium (He) was used as carrier gas with a flow rate of 29.4 mL/ min and an 385 
inlet pressure of 0.19 MPa. The injector was set at 260 °C, the detector at 350 °C and the oven 386 
temperature program was 60 °C for 1 min, at a rate of 40 °C/min, to a final temperature of 310 °C, 387 
and held for 30 min. Apart from ergosterol (ergosta-5,7,22-trien3β-ol) which was the major sterol 388 
(83% of total sterols) and detected at 13.3 min, other sterols such as ergosta-7,22-dienol, ergosta-389 
5,7dienol, ergosta-7-enol (fungisterol), ergosta-4,7,2-trien-3-ona and ergosta-4,6,8(14),22-tetraen-390 
3-ona were also detected at 13.6, 14.0, 14.3, 14.9, and 15.7 min, respectively.  391 
 392 
4. Potential application in the food industry 393 
Efforts have been made to add value to mushroom waste through its use as animal feed, 394 
fuel or to extract valuable compounds that can be used as food safe ingredients, such as chitin, 395 
chitosan, β-glucan, sterols and prebiotic polysaccharides (Chou, Sheih, & Fang, 2013; Gil-396 
Ramírez, Ruiz-Rodríguez, Marín, Reglero, & Soler-Rivas, 2014; Mahfuz, Song, Miao, & Liu, 397 
2019; Vasylenko, Loewe, & Wegener, 2008; Wu, Zivanovic, Draughon, & Sams, 2004). 398 
Furthermore, mushroom-derived β-glucans, lentinan and polysaccharide-K have been used for 399 
thousands of years to improve general health as a part of traditional medicine especially in Asian 400 
countries including China, Japan and Korea (Lemieszek & Rzeski, 2012; Ina, Kataoka, & Ando, 401 
2013).  402 
It is known that mushrooms have the potential to be the only food source of vitamin D 403 
(non-animal and unfortified), while providing a substantial amount of vitamin D2 in a single 404 
serving (Cardwell, Bornman, James, & Black, 2018). Fresh mushrooms sold in UK retailers 405 
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provide 3-5 μg (60-100 % of the RI) per 100 g, which equals to 4-5 chestnut mushrooms or 1-2 406 
portobello mushrooms (Food Manufacture, 2016). 407 
Sun or hot-air dried mushrooms have about 15% of the original weight of fresh mushrooms 408 
and will retain about 5% of water, while freeze dried mushrooms will have close to zero moisture 409 
and 8-10% of the weight of the original mushroom. While dried mushrooms are cheaper to 410 
transport and might represent a cheaper source of vitamin D2, several variables (time of exposure, 411 
temperature, and exposure to UV-B radiation) are known to influence their vitamin D2 production 412 
(Cardwell et al., 2018). 413 
The potential application of waste mushroom extracts (such as vitamin D2 extracts) in new 414 
foods could have regulatory implications. In the European Union, mushroom extracts might fall 415 
under the Novel Food Regulation, which relates to foods not widely consumed by people in the 416 
EU before May 1997. Mushroom extracts could fall under the category “food consisting of isolated 417 
from or produced from plants or their parts” (EFSA, 2016). Only UV treated mushrooms (A. 418 
bisporus) and an aqueous extract from shiitake mushroom with the glucan lentinan (L. edodes) 419 
have so far been authorized as novel foods through the lengthy authorization process.  420 
Practical applications of vitamin D2 from mushroom waste are limited. The concept of 421 
extracting chitin and chitosan from mushroom waste is not new (Wu et al., 2004). Bilbao-Sainz et 422 
al. (2017) developed this concept further, creating vitamin D-fortified chitosan films from 423 
mushroom waste. The authors treated mushroom stalk bases with UV-B light, obtaining about 90 424 
μg of vitamin D2 per gram on a dry weight basis (4.5 to 6 times the RDA/g). They then prepared 425 
fungal chitosan films with characteristics similar to animal derived chitosan. Correa et al., (2018) 426 
obtained and extract rich in ergosterol from commercially discarded A. Blazei fruits and used it as 427 
a fortifier ingredient in yogurts. The ergosterol extract in yogurts had antioxidant properties and 428 
did not alter the nutritional profile of the yogurt. 429 
The use of vitamin D extracts from mushroom waste in new foods could benefit the food 430 
industry, as several nutritional and health claims could be made on food packaging. According to 431 
the European Food Safety Authority (EFSA, 2006), vitamin D can be added to foods as 432 
cholecalciferol (D3) or ergocalciferol (D2). The daily Reference Intake (RI) value for vitamin D is 433 
5 μg, previously known as Recommended Daily Allowances (RDAs), and this is the reference 434 
value used on food labels (EU Regulation, 2011). According to the EFSA register of nutrition and 435 
health claim (EFSA, 2012), there are several health claims that can be made on foods that are a 436 
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“source of” or “high” in vitamin D. “Source of” and “high” refer to foods that contain respectively 437 
at least 15% or 30% of the vitamin D RDA (15%=0.8 μg, 30%=0.16 μg) per 100 g of solid food. 438 
The allowed health claims on vitamin D adapted from the EFSA register of nutrition and health 439 
claims are shown in Table 3. 440 
 441 
5. Potential application in the pharmaceutical industry 442 
Ergosterol, a vital component of the fungal and protozoal cell membranes plays a 443 
fundamental role in membrane fluidity and integrity while acting as a drug target of several 444 
antifungal agents (Rodrigues, 2018). Interestingly, ergosterol and its derivatives isolated from 445 
mushroom and other natural sources have been reported to have several therapeutic properties. A 446 
review by (Picotto, Liaudat, Bohl, & Talamoni, 2012) emphasized the importance of vitamin D 447 
(ergocalciferol and cholecalciferol) in anticancer research. Table 4 represents the major preclinical 448 
studies portrayed in the current literature underlining the bioactivity of ergosterol and its natural, 449 
semi-synthetic and synthetic derivatives. In particular, ergosterol peroxide, a natural ergosterol 450 
derivative has been studied more extensively and shown to confer a greater anti-proliferative and 451 
cytotoxic potential compared to ergosterol against breast, colorectal, ovarian and renal cancer cell 452 
lines (He, Shi, Liu, Zhao, & Zhang, 2018; Kang et al., 2015; L. M. Kuo et al., 2005; Martínez-453 
Montemayor et al., 2019; Russo et al., 2010; Tan et al., 2017).  454 
Mechanistically, ergosterol in its pure or derivative forms were reported to induce caspase-455 
mediated intrinsic apoptosis, arrest cell cycle and inhibit migration and invasion of cancer cells 456 
while regulating several signalling pathways including the STAT3 and the IGFR/IRS-1/2-MEK-457 
ras-ERK1/2 (W. J. Chen et al., 2008; Li et al., 2015; Martínez-Montemayor et al., 2019; Tan et al., 458 
2017). Downregulation of β-catenin has also been identified as one of the key molecular 459 
mechanisms of action against colorectal and renal cancer cells (He et al., 2018; Kang et al., 2015). 460 
β-Catenin is associated with cadherin-mediated intercellular adhesion and the Wnt signalling 461 
pathway (Sineva & Pospelov, 2014).  462 
The AK3/STAT3/NF-κB pathway was found to play an important role in mediating the 463 
anti-inflammatory activity of ergosterol and ergosterol peroxide in cellular and animal models 464 
(Huan, Tianzhu, Yu, & Shumin, 2017; Kobori, Yoshida, Ohnishi-Kameyama, & Shinmoto, 2007; 465 
C.-F. Kuo, Hsieh, & Lin, 2011; Zhang, Xu, Li, & Wang, 2015). The anti-inflammatory activity of 466 
ergosterol has also been attributed to the suppression of the proinflammatory cytokines including 467 
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TNF-α, IL-6 and IL-1β (Huan et al., 2017). Although these reports demonstrated the potential 468 
therapeutic benefits of ergosterol and its derivatives against cancer and inflammatory diseases, 469 
further in vivo mechanistic studies to evaluate their bioavailability and potential toxicity are 470 
warranted to lay the foundation for future clinical trials. Moreover, preclinical studies investigating 471 
the interactions of ergosterol (and its derivatives) with common anticancer and anti-inflammatory 472 
drugs could also open up exciting new avenues for prospective combination therapies especially 473 
for rare cancers and inflammatory diseases with limited therapeutic options. 474 
 475 
6. Future directions 476 
Drying may precede extraction and may affect the retention of both ergosterol and vitamin 477 
D2. Due to the controversial results and limited knowledge regarding ergosterol and vitamin D2 478 
stability during drying, further studies are required in order to elucidate the mechanism of vitamin 479 
D2 formation at different drying temperatures. -Omics technologies, including metabolomics, 480 
genomics, and proteomics may facilitate in better understanding of sterol retention in mushrooms 481 
after the application of different drying techniques. Apart from the conventional drying 482 
technologies that have been applied to date, future studies should be conducted investigating the 483 
effect of ohmic heating (also known as Joule heating) on dried mushroom bioactive compounds. 484 
Ohmic heating is a process of heating the food by passing electric current and may result in faster 485 
dehydration of food, avoiding any color deterioration and nutritional value degradation (Kaur & 486 
Singh, 2016).  487 
The extraction of sterols from mushrooms requires long extraction times when 488 
conventional extraction protocols are applied. The application of non-conventional extraction 489 
technologies such as UAE and MAE may result in pure extracts without saponification decreasing 490 
the extraction times. Future studies should focus on the development of sustainable extraction 491 
protocols on a commercial scale for the recovery of ergosterol and vitamin D2 from mushrooms. 492 
This could be achieved by the combination of two or more different non-conventional extraction 493 
techniques. Pulsed electrical fields (PEF) which is a non-thermal technique has the potential of 494 
being employed for the preparation of pure extracts enriched in vitamin D2 and ergosterol. PEF 495 
may result in an increase mass transfer by electroporation which induces cell membrane 496 
permeabilization (Barbosa-Pereira, Guglielmetti, & Zeppa, 2018).  497 
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The use of vitamin D extracts from mushroom waste in new foods could benefit the food 498 
industry, yet, the practical applications of vitamin D2 from mushroom by-products are limited. 499 
Therefore, potential food applications of mushroom extracts enriched in ergosterol and vitamin D2 500 
is a field that requires further work. Nonetheless, the legislation should be considered when using 501 
vitamin D2 extracts from mushroom waste in new foods. Similarly, despite its potential especially 502 
in anticancer and anti-inflammatory drug development, the pharmaceutical application of 503 
ergosterol and vitamin D2 from mushroom needs further in vivo mechanistic studies for future 504 
clinical trials. As novel drug development entails large resources and time, the approach of 505 
combining pre-existing drugs with natural product-based adjuvants to increase their efficiency is 506 
promising and economical. Therefore, studies investigating the potential synergistic interactions 507 
of ergosterol and vitamin D2 with pre-existing anticancer and anti-inflammatory drugs can provide 508 
interesting insights for their future pharmaceutical applications. 509 
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Figure 1. Process of conversion of ergosterol into vitamin D2 in fungal sources. 849 
Figure 2. Extraction and determination of ergosterol and vitamin D2 by (a) conventional and (b) 850 
non-conventional extraction methods. 851 
































Solvent used Compound 
extracted 
Extraction yields 
(mg/ 100g dw) 
References 
Non-conventional extraction techniques 
A. bisporus MAE Ethanol Ergosterol 555.3 ± 23.6 (Heleno et al., 
2016b) 
A. bisporus UAE Ethanol Ergosterol 671.5 ± 0.5 (Heleno et al., 
2016a) 
A. bisporus DES/UAE  Glycerol: 
Choline 
chloride 
Vitamin D2 1.2 ± 0.3 (Patil et al., 2018) 
A. bisporus DES/MAE Glycerol: 
Choline 
chloride 
Vitamin D2 0.31 ± 0.04 (Patil et al., 2018) 
A. bisporus PLE Ethanol Ergosterol/total 
sterols 
N.M. (Gil-Ramirez et al., 
2013) 




N.M. (Gil-Ramirez et al., 
2013) 
A. bisporus SFE CO2 Ergosterol 39.5 ± 2.8 (Young, 1995) 
T. 
melanosporum, 
T. aestivum, T. 
indicum 
UAE  Chloroform: 
Methanol 
Ergosterol 190 ± 13, 186 ± 25 











Ergosterol Ranged from 23 ± 





L. edodes SFE CO2 Ergosterol, 
Vitamin D2 
 
N.M. (Morales et al., 
2017) 
A. bisporus MAE Methanol Ergosterol 687 ± 0.4 (Young, 1995) 
A. blazei MAE Ethanol Ergosterol 25.44 ± 5.1 (Taofiq et al., 2019) 
A. blazei UAE Ethanol Ergosterol 21.49 ± 0.9 (Taofiq et al., 2019) 
      
Conventional extraction techniques 
A. bisporus SE/saponificati
on  
Ethanol Ergosterol 676 ± 3 (Heleno et al., 
2016a) 
Different species 




Hexane Ergosterol Ranged from 77.0 
± 1.0 to 352.0 ± 
1.0, respectively 
(Barreira, Oliveira, 






Ethanol/Pentane Vitamin D2, 
Ergosterol 
Vitamin D2 ranged 
from 1.25 ± 0.03 to 
4.51 ± 0.31; 
Ergosterol ranged 
from 68 ± 14 to 
780 ± 35 







Ethanol/Pentane Vitamin D2 
 
Vitamin D2 ranged 
from 2.29 ± 0.27 to 
18.4 ± 0.57 








0.38 ± 0.02 (Roberts, Teichert, 
& McHugh, 2008) 
27 
 





Ergosterol 409 ± 1.1 (Young, 1995) 
A. blazei HAE Ethanol Ergosterol 18.84 ± 2.3 (Taofiq et al., 2019) 
A. Bisporus: Agaricus bisporus 878 
DES: Deep eutectic solvents 879 
Dw: Dry weight  880 
HAE: Heat-assisted extraction 881 
L. edodes: Lentinula edodes 882 
LLE: Liquid-liquid extraction 883 
MAE: Microwave-assisted extraction 884 
PLE: Pressurized liquid extraction 885 
SE: Soxhlet extraction 886 
SFE: Supercritical fluid extraction  887 
T. melanosporum: Tuber melanosporum  888 
T. aestivum: Tuber aestivum 889 
T. indicum: Tuber indicum  890 






















Table 2. Summary of high-performance liquid chromatography  (HPLC) conditions been for the detection 911 














Methanol/H2O (95:5, v/v)/ Flow 





(Huang et al., 
2015) 
RP-C18 column/ 40 
°C/ 10 μL 
Ergosterol/ 
Vitamin D2 
Three mobile phases: Methanol 
(A), acetonitrile (B) and 0.05% 
(v/v) formic acid (C)/ Flow rate 
of 1.0 mL/min/ Gradient elution 
 
DAD/ 265 nm (Ahlborn et al., 
2018) 
RP-C18/ 35 °C/ 20 μL Ergosterol Acetonitrile/methanol (70:30, 





(Heleno et al., 
2016b) 
RP C18 column/ 25 
°C/ 10 μL 
Ergosterol Acetonitrile/methanol (75:25, 
v/v)/ Flow rate of 1.5 
mL/min/Isocratic elution 
 
PAD/ 280 nm (Villares et al., 
2014) 
RP C18 column/ 25 
°C/ 20 μL 
Ergosterol Acetonitrile/methanol (75:25, 
v/v)/ Flow rate of 1.5 
mL/min/Isocratic elution 
 
PAD/ 280 nm (Villares et al., 
2012) 
RP-C30 column/ 50 
°C/ 20 μL 
Ergosterol/ 
Vitamin D2 
Methanol 85% (v/v) (A), ethanol 






(Morales et al., 
2017) 




Two mobile phases: 
Methanol/water 80:20 (v/v) (A), 
methanol/dichloromethane, 75:25 
(v/v) (B)/ Flow rate of 1.0 
mL/min/ Gradient elution 
 
PAD/ 280 nm 
for ergosterol 
and 266 nm 
for vitamin D2 
(Yuan, Kuang, 
Wang, & Liu, 
2008) 
RP-C18 column/ room 
temperature/ 20 μL 
Ergosterol Two mobile phases: 
Methanol/water 80:20 (v/v) (A), 
methanol/dichloromethane, 75:25 
(v/v) (B)/ Flow rate of 1.0 
mL/min/ Gradient elution 
 
PDA/ 280 nm  
 






Methanol/acetonitrile 25:75 (v/v)/ 















Acetonitrile/methanol 75:25 (v/v) 










Ergosterol Acetonitrile/methanol 70:30 (v/v) 










Methanol/ Flow rate 0.3 
mL/min/Isocratic elution 
MS/MS (Slawinska et 
al., 2016) 
RP: Reverse phase 913 
UHPLC: Ultra-high-performance liquid chromatography 914 
N.M.: Not mentioned 915 
UV: Ultraviolet  916 
DAD: Diode-array-detector 917 
PAD: Photodiode array detector 918 
MS: Mass spectrometer 919 
d.w.: dry weight 920 


















Table 3. Summary of health claims allowed on foods that are at least a “source of” or “high” in vitamin D. 937 
Claim type Claim Health relationship 
Art.13(1) - Function Health 
Claims' relating to the growth, 
development and functions of 
the body 
Vitamin D contributes to normal 
absorption/utilization of calcium 
and phosphorus 
Absorption and utilization of 
calcium and phosphorus and 
maintenance of normal blood 
calcium concentrations 
Vitamin D contributes to normal 
blood calcium levels 
Absorption and utilization of 
calcium and phosphorus and 
maintenance of normal blood 
calcium concentrations 
Vitamin D contributes to the 
maintenance of normal bones 
Maintenance of bones and teeth 
Vitamin D contributes to the 
maintenance of normal muscle 
function 
Normal muscle function 
Vitamin D contributes to the 
maintenance of normal teeth 
Maintenance of bones and teeth 
Vitamin D contributes to the 
normal function of the immune 
system 
Normal function of immune 
system and inflammation 
response 
Vitamin D has a role in the 
process of cell division 
Cell division 
Art.14(1)(b) - Claims referring 
to children's development 
Vitamin D is needed for normal 
growth and development of 
bone in children. 
 
Vitamin D contributes to the 
normal function of the immune 









Table 4. Preclinical studies underlining the bioactivity of ergosterol and its derivatives and possible molecular mechanisms of action. 
Anticancer activity 
Type of compound 
and derivatives 
Source Study types, cell lines and 
animal models 










In vitro  
MDA-MB-231 and MCF7 
breast cancer, SUM-149, and 
SUM-190 inflammatory 
breast cancer (IBC), KOPN8, 
BCR-ABL, UoCB-1, SUP-
B15, and NALM06 human 
and murine leukemia cells, BJ 
normal human skin fibroblasts 
and MCF10A noncancerous 
mammary epithelial cells. 
Ergosterol peroxide reduced the 
viability of the SUM-149 cells in a 
time- and dose-dependent manner 
(p < 0.05) with EC50 values of 34 
and 20 µM at 24 and 72 h, 
respectively. It also reduced the 
viability of the MDA-MB-231 and 
SUM-190 IBC cells dose-
dependently with EC50 of 19 and 
43 µM, respectively. Presence of 
vacuoles and altered cell 
morphology was observed in 
SUM-49 cells after the treatment 
with ergosterol peroxide. In other 
cancer cells, ergosterol peroxide 
reduced viability with EC50 values 
7 - 22 µM with no cytotoxicity 
against the normal cells. 
Ergosterol peroxide generated 
reactive oxygen species (ROS), 
arrested cell cycle at G1 phase, 
induced apoptosis mediated via 
caspase-3/7 activation, and 
cleavage of PARP. It also 
decreased the migration and 
invasion of cancer cells while 
preventing the expression of total 
AKT1, AKT2, BCL-XL, 
Cyclin D1 and c-Myc in the tested 
IBC cells. Ergosterol peroxide 
sulfonamide, a derivative of 
ergosterol improved the activity 
against IBC cells with a 
therapeutic index of > 10 




Ergosterol peroxide Paecilomyces 
cicadae 
In vitro  
Human renal cell carcinoma 
(RCC) cells 
Significantly inhibited the growth 
of RCC cells with an IC50 value of 
30 µM and significantly decreased 
the colony number compared with 
the control (p < 0.01) in vitro. 
Dose-dependently induced 
apoptosis (caspase-3), inhibited the 
migration and invasion and 
arrested the cell cycle of RCC cells 
at G0/G1 phase with 
downregulation of β-catenin 
expression. 
(He et al., 2018) 
32 
 
Ergosterol peroxide Chemical 
standard 
In vitro  
OVCAR-3, CAOV3, OC-7 
and MPSC-1 ovarian cancer 
and normal OSE cells  
Significantly inhibited the growth 
of cancer cells with no apparent 
cytotoxicity against the normal 
OSE cells. 
Downregulated β-catenin (reduced 
cyclin D1 and c-Myc expression) and 
modulated STAT3 signaling (activation 
of SHP2 phosphatase and inhibition of 
Src kinase) pathways. 








In vitro  
HepG2, SK-Hep1human 
hepatocellular carcinoma,  
and MCF7, MDA-MB231 
human breast cancer cells  
 
Significant antiproliferative activity 
by 5α,8α-Epidioxyergosta-3-yl-
(piperazine-1) carbamate and 
5α,8α-epidioxyergosta-3-yl-
(piperidin-4-ethylamine)carbamate 
and their hydrochloride salts in 
vitro with IC50 values 0.85 - 4.62 
μM. 
5α,8α-Epidioxyergosta-3-yl-
(piperazine-1) carbamate showed 
mitochondrial localization. 
(Bu et al., 2017) 
Ergosterol derivatives Ganoderma 
lucidum 
In vitro  
MDA-MB-231, HepG2, and 
A549 cancer, human 
umbilical vein endothelial 
(HUVECs)and normal 
NIH/3T3 fibroblast cells 
(3β, 5α, 6β, 22E)-ergosta-7, 9 (11), 
22-triene-3, 5, 6-triol exhibited 
selective toxicity against MDA-MB-
231 and HepG2 cells with IC50 
values 56.3 - 62.5 μM.  (3β, 5α, 6β, 
9α, 22E)-ergosta-7, 22-diene-3, 5, 6, 
9-tetrol showed selective toxicity 
against HUVECs.  Compounds did 
not show cytotoxicity against the 
normal cells. 
Not reported (Chen et al., 
2017) 
Ergosterol peroxide Inonotus 
Obliquus 
In vitro 
HCT116, HT-29, SW620 and 






C57BL/6 female mice  
Dose-dependent reduction of 
cellular viability of the tested cancer 
cell lines. Time-dependent reduction 
of anchorage-dependent colony 
formation.   Suppressed tumour 
growth in AOM/DSS-treated mice. 
Induced caspase-3 mediated apoptosis, 
PARP cleavage and arrested all CRC 
cells at subG1 stage. Suppressed the 
nuclear levels of β-catenin leading to 
reduced transcription of c-Myc, cyclin 
D1, and CDK-8. 






In vitro  
MDA-MB-231, SK-BR-3, 
MDA-MB-468, MCF7, and 
4T1 breast cancer and 
NIH3T3 non cancer fibroblast 
cells. 
Time and dose-dependent reduction 
of cellular viability of the tested 
cancer cell lines with no 
cytotoxicity against the NIH3T3 
cells. At 75 μM, it inhibited the 
colony formation in both the sizes 
and number of the colonies of 
MDA-MB-231 cells. Prolonged the 
survival of B16-induced tumour-
bearing Balb/c mice. 
Induced apoptosis, inhibited cell 
migration and invasion with 
upregulation of tumour suppressors- 
Foxo3, Bim, Fas, and Fas L in MDA-
MB-231 cells 





In vitro  
PC3 human prostatic 
carcinoma and MDA-MB-231 
breast carcinoma cells 
Ergosterol (9.82- >100 µM) and 
ergosterol peroxide (30.23- 38.19 
µM) exhibited cytotoxicity against 
the PC3 and MB-231 cells. 
Not reported (Ma, Chen, 







In vitro  
SKOV-3 human ovarian 
epithelial adenocarcinoma, 
BxPC-3 human pancreatic 
adenocarcinoma, PC-3 and 
LNCaP human prostate 
adenocarcinoma, SH- SY5Y, 
SMS-KCNR and SK-N-SH 
human neuroblastoma cells  
 
Displayed significant cytotoxicity 
against SKOV-3 and PC-3 cancer 
cells (with the IC50 values in the 
range of 100-300 nM) but not 
against the other tested cell lines. 
Significantly greater cytotoxicity 
was observed against SKOV-3 cells 
compared to cisplatin, Iressa and 
the vitamin-D receptor (VDR) 
ligands- calcitriol and EB1089. The 
cytotoxicity was comparable to 
Taxol. 
Caspase dependent apoptosis, DNA 
fragmentation and cell cycle abrogation 
in SKOV-3 cells. Downregulated the 
IGFR/IRS-1/2-MEK-ras-ERK1/2-
pathway via activated TNFα-
receptor/SAPK/JNK component 
without altering VDR. 












In vitro  
LNCaP and DU-145 human 
prostate cancer cells 
Ergosterol peroxide and (22E)-
ergosta-7,22-dien-5α-hydroxy-3,6-
dione exhibited significant cell 
growth inhibition in the MTT assay 
with the IC50 values in the range of 
6.12 – 24.03 µM/mL against both 
cell lines. Ergosterol was reported 
to have an IC50 value of > 100 
µM/mL against both cell lines.  
Ergosterol peroxide and (22E)-ergosta-
7,22-dien-5α-hydroxy-3,6-dione 
induced apoptosis with a significant 
increase in caspase-3 activity, marker of 
membrane breakdown and DNA 
fragmentation. 






In vitro  
HL-60 human 
leukemia cells 
Dose-dependent cell growth inhibition 
was exhibited by ergocalciferol and 
ergosterol.  Ergocalciferol displayed 
better activity than ergosterol. 
Induced DNA fragmentation and 
increased sub-G1 DNA contents in HL-
60 cells.  Modulated mitochondrial 
ROS production, GSH depletion and 
Fas induction. Induced caspase (2, -3, -




6, and -9) dependent apoptosis as 
indicated by the cleavage of 
downstream caspase-3 targets, DNA 
fragmentation factor (DFF-45), and 
PARP.  Reduced Mcl-1 to Bax ratio 
indicating mitochondrial decay. 
Ergosterol peroxide Penicillium 
oxalicum 
In vitro  
COLO-205 human colon 
tumour, KB human oral 
epithelium carcinoma, Hepa-
3B hepatoma and Hela 
cervical carcinoma cells  
Displayed cytotoxicity against the 
COLO-205 cells with an ED50 of 8.56 
μg/mL. No activity against the other 
cell lines.  
Inhibited the relaxation of supercoiled 
DNA (pBR322) induced by DNA 
topoisomerase I. 
(Kuo et al., 
2005) 
Ergosterol peroxide Sarcodon 
aspratus 
In vitro  
HL-60 human leukemia cells 
Cell growth inhibition at a dose of >10 
μM. 





Ergosterol peroxide Paecilomyces 
tenuipes 
In vitro  
SNU-1 human gastric tumour, 
SNU-354 human hepatoma, 
SNU-C4 human colorectal 
tumour and murine sarcoma-
180 cells 
The IC50 values were 18.7, 158.2, 84.6 
and 74.1 µM against the SNU-1, 
SNU-354, SNU-C4 and murine 
sarcoma-180 cells lines, respectively. 





Type of compound 
and derivatives 
Source Study types, cell lines and 
animal models 




Cigarette smoke (CS)- 
induced chronic obstructive 
pulmonary disease (COPD) in 
male ICR mice 
 
Inhibited CS-induced pathological 
injury in lung tissue.  
 
Restored superoxide dismutase activity 
in the serum and the lung and catalase 
activity in serum. Decreases the content 
of Malondialdehyde in the serum and 
the lung. Inhibited pro-inflammatory 
cytokines including tumour necrosis 
factor-α (TNF-α), interleukin-6 (IL-6), 
and interleukin-1β (IL-1β) in serum and 
the lung. Protective effect on CS-
induced COPD by inhibiting 











Ergosterol pretreatment at 25 and 50 
mg/kg decreased lipopolysaccharide 
(LPS)-induced lung histopathological 
changes and lung wet-to-dry weight 
ratio 
Suppressed inflammatory cells and 
proinflammatory cytokines including 
TNF-α and IL-6. Blocked the activation 
of NF-κB, COX-2 and iNOS pathways. 






In vitro  
BV2 microglia cells 
Dose-dependent reduction of NO 
production ranging from 13% to 48% 
at 1 μg/mL – 10 μg/mL with no 
cytotoxicity at 0.1-10 μg/mL. 
Commercial ergosterol was not 
effective. 






In vitro  
RAW 264.7 murine 
macrophage cells 
Inhibited the production of nitric 
oxide (NO). 




In vitro  
RAW 264.7 murine 
macrophage cells 
Dose-dependent cytotoxicity with IC50 
of 24.5 µg/mL 
Downregulated NF-κB cascade-
associated proteins, inhibited TNF- α 
production and COX-2 expression and 
modulated Rho family GTPase and 
cytoskeleton-related proteins at 10 
µg/mL. 
(Kuo et al., 
2011) 
Ergosterol Saireito In vitro  
Mucosal-type murine bone 
marrow-derived mast cells 
(mBMMCs) 
The degranulation of mBMMCs was 
significantly suppressed at ≥32 µM in 








Ergosterol peroxide Heritiera 
littoralis bark 
In vitro  
RAW 264.7 murine 
macrophage cells 
Inhibited NO and PGE2 release with 
the IC50 values of 2.5 µM and 28.7 
µM, respectively. 
Dose-dependent downregulation of 













- Ergosterol peroxide and 5a,8a-
epidioxy-(24S)-ergosta-6-en-3b-ol 
selective inhibitory activity against 
Crotalus adamenteus venom 






phospholipase A2 (PLA2) enzyme 
with an ED50 value of 100 µg/mL 
Ergosterol peroxide Sarcodon 
aspratus 
In vitro  
RAW264.7 mouse 
macrophage and 
HT29 human colorectal 
adenocarcinoma cells 
Ergosterol peroxide suppressed LPS-
induced TNF-α secretion and IL-1α/β 
expression in RAW264.7 cells 
Suppressed NF-kB and C/EBPβ 
transcriptional activity, and 
phosphorylation of MAPKs.  Inhibited 
cell growth and STAT1 mediated 
inflammatory responses by modulating 
the redox state in 
HT29 cells. 
(Kobori et al., 
2007) 
Ergosterol peroxide Cordyceps 
cicadae 
In vitro  
Primary human T 
lymphocytes 
Inhibited T-cell proliferation for about 
24 h after stimulation with 
phytohemagglutinin (PHA). 
Suppressed the expression of cyclin E, 
IFN-γ, IL-2, and IL-4, and by arrested 
cell cycle progression from the G1 to 
the S phase in T lymphocytes.  
Downregulated AP-1 proteins including 









Normal human serum Ergosterol and ergosterol peroxide 
displayed anti-complimentary activity 
on the classical pathway with IC50 
values of 5 and 1 μM, respectively. 
Not reported (Kim et al., 
1997) 
Other bioactivity 
Type of compound 
and derivatives 
Source Study types, cell lines and 
animal models 




In vitro  
Trypanosoma cruzi 
maintained in LLC-MK2 
cells, peritoneal macrophages 
from the peritoneal cavity of 
female BALB/c mice 
Exhibited antiparasitic activity against 
trypomastigotes, with an IC50 value of 
51.3μg/mL with no cytotoxicity 
against mammalian peritoneal 
macrophages even at 200 μg/mL.  
 
Permeabilization of the plasma 
membrane and depolarization of 
mitochondrial membrane 
Potential. No ROS generation. 
(Alexandre et 
al., 2017) 
Ergosterol peroxide Cordyceps 
cicadae 
In vitro  
Transforming growth factor-
β1 (TGF-β1) treated NRK-
49F normal rat kidney 
fibroblast cells 
Mitigated the proliferation of renal 
fibroblast cells in dose (6.25-25 µM) 
and time-dependent manner. 
Downregulated the expression of 
cytoskeleton protein and CTGF and 
ECM production. Inhibited TGF-β1-
stimulated phosphorylation of ERK1/2, 
p38 and JNK pathway. 
(Zhu, Zheng, 





LX-2 human hepatic stellate 
and HL-7702 human hepatic 
cell lines  
Ergosterol inhibited activated LX-2 
and HL-7702 cells in a dose-
dependent manner. It protected the 
Upregulated expressions of 
permeability of the lysosomal 
membrane and downregulated the levels 
of EdU, F-actin, and 𝛼-SMA.  









Male C57BL/6 mice 
liver against CCl4-induced hepatic 
fibrosis in vivo at a 50 mg/kg dose.  
Improved- serum liver function and 
expression of 𝛼-SMA in vivo. Reduced- 
liver/BW or spleen/BW, hepatic 
inflammation and collagen deposition in 
vivo. 
